Job description

Requirements

  • Entry level
  • No Education
  • Salary to negotiate
  • Basel

Description

At Roche, we believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives and we are brave in both decision and action. And we believe that good business means a better world.
That is why we come to work every single day. We commit ourselves to scientific rigour, unassailable ethics, and access to medical innovations for all. We do this today to build a better tomorrow.
Global Product Strategy (GPS) drives Roche’s strategy and portfolio of products - from research through to patients. As a member of GPS, you will be part of a truly international group who collaborates with functions and affiliates worldwide to shape the future of medicine.
The Global Access (GA) department at F. Hoffmann-La Roche, Ltd. based in Basel, Switzerland is seeking a Global HTA (Health Technology Assessment) Evidence Lead to join the Global HTA Evidence group within the Access Center of Excellence. This position would report to a Global HTA Evidence Team Enabler.
As a Global HTA Evidence Lead you will work with colleagues across the global organization (commercial and development) and local market access representatives to develop the HTA Evidence strategies and packages supporting decisions which determine access to Roche’s innovative offerings.
You will collaborate to develop the evidence package used by payers and other Health Technology Assessment bodies to support both the pre-launch and launch stage of reimbursement process. In the pre-launch phase, you will work to identify evidence gaps and data sources, design and execute evidence generation plans, and conduct analyses to address molecule and disease area questions to inform access and the broader integrated business. You will also contribute to functional, cross-functional, enterprise-wide or external initiatives that shape our business and healthcare environments including the application of novel methodologies used to support HTA decision-making. This requires a good understanding of integrated access strategies, integrated evidence plans, healthcare environments, affiliate pricing & reimbursement needs, as well as strong scientific and technical expertise. You will need strong strategic, collaboration and communication skills, as well as a solution-driven and entrepreneurial mindset.
In this job you should have the ability to communicate clear integrated access evidence strategies and methodologies and insights derived from evidence used within HTA to diverse audiences. This requires an understanding of the broader context and how evidence can impact access and broader commercialization strategies. Collaborate with colleagues across the organization to provide expertise required for the preparation of evidentiary plans and their application within HTA / reimbursement dossiers as well as more broadly implement access and commercialization strategies. Design and implement HTA evidentiary strategies: developing evidence to support HTA decision making including decision analytical models, network meta-analyses and/or the analysis of clinical trial data.
Your responsibilities include:
Provide input into the design of clinical development programs to ensure evidence needs for HTA are considered within the global development and commercialization strategies
Ensure that all functional activities are strategically aligned with other functions within Global Access and the wider organization (affiliates, Product Development, commercial and others)
Actively contribute to continuous improvement within the HTA Evidence Group
Keeps up to date with changing HTA landscape and academic research areas to ensure that current access trends and methodologies are incorporated into evidentiary plans and strategies
Lead or contribute to cross-functional sub-teams within an existing global matrix team
Build and maintain relationships with relevant external health economic, statistics, HTA, and policy experts and contributes to the development of methodologies relevant for HTA and payer activities
Plan and execute health economic and/or statistical analyses on clinical trial data and other relevant data sources consideration of the input/feedback from affiliates and global colleagues to support access decision-making
Develop supportive technical documentation of economic and statistical analyses and supports interpretation of findings with appropriate communication methods
Work closely with

About the company

Roche is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has bearer shares listed on the SIX Swiss Exchange.

The company headquarters are located in Basel and the company has many pharmaceutical and diagnostic sites around the world – including: Tucson, AZ; Pleasanton, CA; Vacaville, California, Oceanside, California, Branchburg, NJ; Indianapolis, Indiana; Florence, South Carolina; and Ponce, Puerto Rico in the US; Welwyn Garden City and Burgess Hill in the UK; Clarecastle in Ireland; Mannheim and Penzberg in Germany; Mississauga and Laval in Canada; Shanghai in China; Mumbai & Hyderabad in India; São Paulo and Rio de Janeiro, Brazil; Segrate, Milan in Italy; Johannesburg in South Africa; Karachi, Islamabad and Lahore in Pakistan. There are 26 manufacturing sites worldwide.

Companies in this sector